23 Feb VERIGRAFT
Petter Bjorquist, Ph.D., CEO
Oct. 7 | 5:00pm | FLW Ballroom G
Gothenburg, Sweden
(Private)
VERIGRAFT is a pioneer in regenerative medicine since 2014 and has grown to become a forerunner in industrialized tissue therapies and advanced regenerative medicine. The company has a strategically focused R&D pipeline of personalized tissues, targeting areas such as cardiovascular and neuronal disease for a global market. With state-of-the-art labs and offices near Gothenburg University and Sweden’s largest hospital, VERIGRAFT is strategically positioned. The mission involves commercializing personalized tissue-engineered grafts to address incurable diseases, significantly impacting patients’ lives and socio-economic factors. VERIGRAFT offers a unique, breakthrough technology that will be able to bring a paradigm shift in transplantation medicine. Guided by a team of experienced scientists and entrepreneurs, VERIGRAFT has secured support from investors globally, poised to make a significant difference in the lives of patients worldwide.
